TY - JOUR

T1 - Forebyggelse og behandling af stråleterapiinduceret kvalme og opkastning

AU - Ruhlmann, Christina

AU - Petersen, Peter Clausager

AU - Herrstedt, Jørn

PY - 2019

Y1 - 2019

N2 - This review summarizes the current knowledge of radiation-induced nausea and vomiting (RINV), which occurs in ap-proximately 50% of patients undergoing radiotherapy. Poor control of the symptoms may result in dehydration and electrolyte disturbances leading to delay or even disruption of the planned schedule, which in turn results in decreased disease control. Patients report RINV as distressing symp-toms, and under-treatment is a major problem. Evidence-based antiemetic guidelines have been developed, but lack of adherence is a barrier to improvement of symptom control and quality of life during radiotherapy.

AB - This review summarizes the current knowledge of radiation-induced nausea and vomiting (RINV), which occurs in ap-proximately 50% of patients undergoing radiotherapy. Poor control of the symptoms may result in dehydration and electrolyte disturbances leading to delay or even disruption of the planned schedule, which in turn results in decreased disease control. Patients report RINV as distressing symp-toms, and under-treatment is a major problem. Evidence-based antiemetic guidelines have been developed, but lack of adherence is a barrier to improvement of symptom control and quality of life during radiotherapy.

KW - Antiemetics/therapeutic use

KW - Humans

KW - Nausea/prevention & control

KW - Quality of Life

KW - Radiotherapy/adverse effects

KW - Research

KW - Vomiting/prevention & control

M3 - Tidsskriftartikel

C2 - 31366424

VL - 181

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

M1 - V02190116

ER -